AGN 4.20% 68.5¢ argenica therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 520 Posts.
    lightbulb Created with Sketch. 322
    Excellent Quarterly.

    -According to my best estimates Phase 1 will commence Q2.

    -Capital expenditure/control has been excellent.

    -Communication continues to be excellent.

    -Patent granted in The US on 25th of January for ARG-007's various indications.

    Overall, very very happy.


 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
68.5¢
Change
-0.030(4.20%)
Mkt cap ! $87.74M
Open High Low Value Volume
72.0¢ 72.0¢ 68.0¢ $68.58K 98.13K

Buyers (Bids)

No. Vol. Price($)
1 400 69.0¢
 

Sellers (Offers)

Price($) Vol. No.
72.0¢ 40000 1
View Market Depth
Last trade - 15.26pm 01/10/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.